Inflectra now known as Remdantry
April 1, 2025PIPProviders
Effective April 1, 2025, all historic patient records in the Pharmaceutical Information Program (PIP) for Inflectra will appear as Remdantry. Remdantry is the new name of the biosimilar product formerly known as Inflectra.